Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance

Tongxin Wang,Kai Chen,Weilei Yao,Ruilong Zheng,Qiongyu He,Jun Xia,Juan Li,Yafei Shao,Li Zhang,Lu Huang,Longshan Qin,Mingming Xu,Zheng Zhang,Dingyu Pan,Zhen Li,Feiruo Huang
DOI: https://doi.org/10.1016/j.jhep.2020.11.028
IF: 25.7
2021-05-01
Journal of Hepatology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background and Aims</h3><p>Lactate has been recently reported to accumulate in the liver with the progression of hepatosteatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) for lactate accumulation and the role of lactate in the NAFLD progression is essentially unknown.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Acetylome of normal, nonalcoholic fatty liver (NAFL), and nonalcoholic steatohepatitis (NASH) samples of human livers were compared to determine the potential acetylated target of lactate metabolism. The interaction of acetylated target and acetyltransferase was measured in multiple cell lines. Inhibitor of the acetyltransferase were injected to high-fat diet (HFD) fed mouse to determine the function of lactate on NAFLD progression in vivo.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in human and mouse. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decreased LDHB activity and impaired hepatic lactate clearance, resulting in lactate accumulation in NAFLD progression. Acetylated LDHB-induced lactate accumulation exacerbated lipid <a href="https://www.mdpi.com/2073-4409/8/3/205">deposition</a> and inflammatory responses via activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, the inhibitor of the PCAF and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>PCAF-dependent LDHB acetylation plays a key role in the development of hepatic lipid accumulation and inflammatory responses by imparing lactate clearance; and might be a potential therapeutic target for treatment of NASH.</p>
gastroenterology & hepatology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: the mechanism of lactic acid accumulation during the progression of non - alcoholic fatty liver disease (NAFLD) and its impact on the disease process. Specifically, the study aims to explore how the acetylation of lactate dehydrogenase B (LDHB) affects the clearance of lactic acid in the liver and further leads to the exacerbation of NAFLD. ### Research Background and Objectives Non - alcoholic fatty liver disease (NAFLD) is a common chronic liver disease, and its clinical manifestations include non - alcoholic fatty liver (NAFL) and non - alcoholic steatohepatitis (NASH). As NAFL progresses to NASH, the lactic acid level in the liver increases significantly, but the specific mechanism of lactic acid accumulation and its role in the progression of NAFLD are still unclear. This study aims to reveal the role of LDHB acetylation in this process. ### Research Methods 1. **Protein Acetylomics Analysis**: Compare liver samples from normal, NAFL, and NASH patients to identify potential acetylation targets related to lactic acid metabolism. 2. **Cell Experiments**: Measure the interaction between acetylation targets and acetyltransferases. 3. **Animal Experiments**: By injecting acetyltransferase inhibitors (such as Embelin), study the effect of lactic acid on the progression of NAFLD. ### Main Findings 1. **High Acetylation of LDHB**: The study found that in the livers of NAFL and NASH patients, the acetylation level of LDHB increased significantly, especially at the K82 site. 2. **PCAF - Mediated Acetylation**: The acetylation of LDHB at the K82 site mediated by P300/CBP - associated factor (PCAF) significantly reduced the activity of LDHB, thereby hindering the clearance of lactic acid in the liver and leading to lactic acid accumulation. 3. **Impact of Lactic Acid Accumulation**: The lactic acid accumulation induced by acetylated LDHB exacerbates lipid deposition and inflammatory responses, which may be achieved by activating histone hyperacetylation. 4. **Therapeutic Potential**: Using the PCAF inhibitor Embelin or generating an acetylation - deficient LDHB mutant can improve NASH symptoms. ### Conclusion PCAF - dependent LDHB acetylation plays a key role in the development of NAFLD by hindering lactic acid clearance, leading to lipid accumulation and inflammatory responses. Therefore, PCAF - dependent LDHB acetylation may become a potential target for the treatment of NASH. ### Mathematical Formulas When describing certain experimental results, some mathematical formulas may be used, for example: - Ratio of lactate to pyruvate: \[ \text{Lactate to Pyruvate Ratio}=\frac{\text{[Lactate]}}{\text{[Pyruvate]}} \] These formulas help to express experimental data and results more accurately. ### Summary This study reveals the important role of LDHB acetylation in the progression of NAFLD, provides a new perspective for understanding the mechanism of lactic acid accumulation, and proposes potential treatment strategies.